Acetaminophen and Blincyto drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Acetaminophen (acetaminophen) and Blincyto (blinatumomab). Common drug interactions include pyrexia among females and pyrexia among males.
The phase IV clinical study analyzes what interactions people have when they take Acetaminophen and Blincyto. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.
What is Acetaminophen?
Acetaminophen has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 183,077 Acetaminophen users. Check the latest studies of Acetaminophen.
What is Blincyto?
Blincyto has active ingredients of blinatumomab. eHealthMe is studying from 6,058 Blincyto users. Check the latest studies of Blincyto.
20 people who take Acetaminophen and Blincyto together, and have interactions are studied.

What are the common drug interactions of Acetaminophen and Blincyto, by gender? *:
female:
- Pyrexia (fever)
- Central nervous system leukaemia (cancer of central nervous system)
- Device related infection
- Gingival pain (gum pain)
- Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
- Leukaemic infiltration gingiva (cancer cells of white blood cells affects gums)
- Neutropenia (an abnormally low number of neutrophils)
- Thrombocytopenia (decrease of platelets in blood)
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
male:
- Pyrexia (fever)
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Tumour marker increased
- Upper respiratory tract infection
- Upper respiratory tract inflammation
- Vomiting
- Pneumonia
- Abdominal pain lower
- Blood lactate dehydrogenase decreased
What are the common drug interactions of Acetaminophen and Blincyto, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Pyrexia (fever)
- Central nervous system leukaemia (cancer of central nervous system)
- Device related infection
- Gingival pain (gum pain)
- Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
- Leukaemic infiltration gingiva (cancer cells of white blood cells affects gums)
- Neutropenia (an abnormally low number of neutrophils)
- Myelosuppression (a decrease in the production of blood cells)
- Fungal infection
- Meningitis bacterial (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
10-19:
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Hypotension (abnormally low blood pressure)
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Abdominal pain upper
- Hypoxia (low oxygen in tissues)
- Pyrexia (fever)
- Apnoea (suspension of external breathing)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
20-29:
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Subdural haematoma (blood collects between the skull and the surface of the brain)
- Thrombocytopenia (decrease of platelets in blood)
- Venoocclusive disease (small veins in the liver are obstructed)
- Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
- Neoplasm recurrence (reoccurrence of tumour)
30-39:
- Abdominal pain lower
- Blood lactate dehydrogenase decreased
- Burkitt's lymphoma recurrent (recurrent blood cancer)
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
- Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
- Pyrexia (fever)
- Skin reaction
40-49:
n/a
50-59:
n/a
60+:
- Rectal cancer (cancer of rectum)
- Thrombocytopenia (decrease of platelets in blood)
What are the existing conditions these people have? *
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 10 people, 50.00%
- B Precursor Type Acute Leukaemia (lymphoid cancer): 6 people, 30.00%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 5 people, 25.00%
- Fever: 4 people, 20.00%
- High Blood Pressure: 3 people, 15.00%
- Device Related Infection: 3 people, 15.00%
- Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 2 people, 10.00%
- Leukaemia Recurrent (repeat cancer of bone marrow or blood cells): 2 people, 10.00%
- Insomnia (sleeplessness): 1 person, 5.00%
- Depression: 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Acetaminophen and Blincyto?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Acetaminophen (183,077 reports)
- Blincyto (6,058 reports)
Browse all drug interactions of Acetaminophen and Blincyto:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Acetaminophen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Blincyto:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Acetaminophen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Blincyto and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on acetaminophen and blinatumomab (the active ingredients of Acetaminophen and Blincyto, respectively), and Acetaminophen and Blincyto (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Glumetza cause Device Related Infection? - 5 seconds ago
- Could Paclitaxel cause Dizziness? - 6 seconds ago
- Drug interactions of Bydureon Bcise and Novolog - 13 seconds ago
- Drug interactions of Promethazine and Triamcinolone - 14 seconds ago
- Could Ibrutinib cause Ventricular Tachycardia? - 15 seconds ago
- Drug interactions of Nimbex and Diflucan - 16 seconds ago
- Could Tysabri cause Arthritis Infective? - 20 seconds ago
- Could Verzenio cause Drug Eruption? - 22 seconds ago
- Drug interactions of Prezcobix and Amoxicillin - 24 seconds ago
- Drug interactions of Tafluprost and Temaz - 28 seconds ago